Professor Alan Parker
By creo
Working from basic virology to translational oncology, involving the manipulation and engineering of adenoviruses into advanced therapeutic agents for the treatment of cancers.
By creo
Working from basic virology to translational oncology, involving the manipulation and engineering of adenoviruses into advanced therapeutic agents for the treatment of cancers.
By creo
Specialising in immunology and co-founder of the Gallimore Godkin lab which takes basic research using model systems of cancer through to testing novel immunotherapies in patients with cancer.
Specialising in head and neck cancer and Director of the Wales Cancer Research Centre.